| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |